Ifosfamide Export Market Intelligence: India's 152 Suppliers Shipping to 80 Countries — TransData Nexus 2026

Q: Who are the top ifosfamide exporters from India?

The top ifosfamide exporters from India are: 1. VIVALIA REMEDIES PRIVATE LIMITED — $608.7K (24.9% market share); 2. UNITED BIOTECH PRIVATE LIMITED — $335.3K (13.7% market share); 3. GETWELL PHARMACEUTICALS — $296.0K (12.1% market share); 4. KWALITY PHARMACEUTICALS LIMITED — $177.0K (7.2% market share); 5. DAB PHARMA — $105.8K (4.3% market share). Together they account for 62.3% of India's total ifosfamide export value.

Q: What is the total export value of ifosfamide from India?

The total export value of ifosfamide from India is $2.4M USD, recorded across 732 shipment transactions from 152 active exporters to 80 destination countries. The average shipment value is $3.3K.

Q: Which countries import ifosfamide from India?

India exports ifosfamide to 80 countries worldwide. The top importing countries are: UZBEKISTAN (25.1% share, $614.3K), PHILIPPINES (12.8% share, $311.5K), PERU (11.5% share, $280.6K), PAKISTAN (6.2% share, $150.7K), VENEZUELA (5.2% share, $126.4K). These five markets account for 60.7% of total export value.

Q: What is the HS code for ifosfamide exports from India?

The primary HS code for ifosfamide exports from India is 30049049. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of ifosfamide exports from India?

The average unit price for ifosfamide exports from India is $9.63 USD per unit, with prices ranging from $0.08 to $1469.87 depending on formulation, packaging, and order volume. The total market is valued at $2.4M across 732 shipments.

Q: Which ports handle ifosfamide exports from India?

The primary ports for ifosfamide exports from India are SAHAR AIR CARGO ACC (INBOM4) (22.7% of shipments), SAHAR AIR (18.6% of shipments), DELHI AIR CARGO ACC (INDEL4) (17.8% of shipments), DELHI AIR (12.8% of shipments), Bombay Air (8.2% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of ifosfamide?

India is one of the world's leading exporters of ifosfamide due to its large base of 152 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports ifosfamide to 80 countries, demonstrating 41% global market coverage.

Q: What certifications do Indian ifosfamide exporters need?

Indian ifosfamide exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import ifosfamide from India?

There are 236 registered buyers importing ifosfamide from India, spread across 80 countries. The repeat buyer rate is 48.3%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top ifosfamide supplier from India?

VIVALIA REMEDIES PRIVATE LIMITED is the leading ifosfamide exporter from India with a market share of 24.9% and total export value of $608.7K across 7 shipments. The top 5 suppliers together control 62.3% of total export value.

Suresh Sormare

Ifosfamide

India Pharmaceutical Trade Intelligence

$2.4M152 Suppliers80 CountriesHS 30049049

ExportsIndia → UZBEKISTAN25.1%India → PHILIPPINES12.8%

ImportsUNITED STATES → India$4.5K

#1 Supplier: VIVALIA REMEDIES #1 Buyer: VEF SAU

Ifosfamide Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Ifosfamide to the World

Between 2022 and 2026, India exported $2.4M worth of ifosfamide across 732 verified shipments to 80 countries — covering 41% of world markets in the Advanced Oncology segment. The largest destination is UZBEKISTAN (25.1%). VIVALIA REMEDIES PRIVATE LIMITED leads with a 24.9% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Ifosfamide export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Ifosfamide export data snapshot — $2.4M · 152 exporters · 80 countriesTransData Nexus · Indian Customs Data

Top Ifosfamide Exporters from India

152 active exporters · Ranked by export value

View all 152 →

Top Ifosfamide Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	VIVALIA REMEDIES PRIVATE LIMITED	$608.7K	7	1	24.9%
2	UNITED BIOTECH PRIVATE LIMITED

Top Countries Importing Ifosfamide from India

80 destination markets · Ranked by import value

All 80 countries →

Top Countries Importing Ifosfamide from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UZBEKISTAN	$614.3K	25.1%
2	PHILIPPINES	$311.5K	12.8%
3	PERU	$280.6K	11.5%
4	PAKISTAN	$150.7K	6.2%
5	VENEZUELA	$126.4K	5.2%
6	SRI LANKA	$98.1K	4.0%
7	KENYA	$94.7K	3.9%
8	NEPAL	$73.3K	3.0%
9	LEBANON	$62.1K	2.5%
10	YEMEN	$53.3K	2.2%

UZBEKISTAN is India's largest ifosfamide export destination, absorbing 25.1% of total exports worth $614.3K. The top 5 importing countries — UZBEKISTAN, PHILIPPINES, PERU, PAKISTAN, VENEZUELA — together account for 60.7% of India's total ifosfamide export value. The remaining 75 destination countries collectively receive the other 39.3%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Ifosfamide to India?

1 origin countries · Total import value: $4.5K

India imports ifosfamide from 1 countries with a combined import value of $4.5K. The largest supplier is UNITED STATES ($4.5K, 2 shipments), followed by . All values are from Indian Customs (DGFT) import records.

Countries Supplying Ifosfamide to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$4.5K	2	100.0%

UNITED STATES is the largest supplier of ifosfamide to India, accounting for 100.0% of total import value. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Ifosfamide

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Ifosfamide was first approved by the FDA on December 30, 1988, under the brand name Ifex, manufactured by Baxter Healthcare. The FDA has since approved generic versions, with Fresenius Kabi USA receiving approval on May 28, 2002, for 1g and 3g vials. As of February 12, 2026, these generics are available in the market.

The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for ifosfamide, indicating a competitive generic market. Given that 152 Indian exporters are actively involved in the ifosfamide trade, compliance with FDA regulations, including Good Manufacturing Practices (GMP) and proper labeling, is crucial to maintain market access.

2EU & UK Regulatory Framework

In the European Union, ifosfamide-containing medicines, such as Holoxan, are subject to EMA regulations. A manufacturing issue identified during a regulatory inspection in September 2025 led to a temporary halt in production, resulting in a shortage expected to last until Q1 2027. This shortage affects all EU/EEA Member States. (ema.europa.eu)

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) aligns with EMA standards, requiring marketing authorization holders to adhere to EU GMP guidelines. Indian exporters must ensure compliance with these standards to maintain access to the UK market.

3WHO Essential Medicines & Global Standards

Ifosfamide is included in the World Health Organization's Model List of Essential Medicines, underscoring its importance in treating various cancers. The 10th List (2025) specifies its use for conditions such as anaplastic large cell lymphoma, Burkitt lymphoma, Ewing sarcoma, nephroblastoma, osteosarcoma, ovarian germ cell tumors, rhabdomyosarcoma, and testicular germ cell tumors. (iris.who.int)

Compliance with international pharmacopoeia standards, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), is essential for Indian exporters to meet global quality requirements.

4India Regulatory Classification

In India, ifosfamide is classified under Schedule H of the Drugs and Cosmetics Act, indicating it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates its pricing under the Drug Price Control Order (DPCO). Exporters must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for exporting ifosfamide, ensuring compliance with national regulations.

5Patent & Exclusivity Status

The original patents for ifosfamide have expired, leading to a competitive generic market. As of February 4, 2026, there are no active U.S. patents for ifosfamide, allowing multiple manufacturers to produce and market generic versions.

6Recent Industry Developments

In September 2025, a regulatory inspection at a European manufacturing site led to a temporary halt in ifosfamide production, causing a shortage expected to last until Q1 2027. (ema.europa.eu)

In February 2026, the FDA updated its records to confirm the availability of generic ifosfamide versions, reflecting a stable supply in the U.S. market.

These developments highlight the dynamic nature of the ifosfamide market, emphasizing the need for Indian exporters to stay informed about regulatory changes and market conditions to maintain and expand their global presence.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Ifosfamide

Retail & reference prices across 9 markets vs. India FOB export price of $9.63/unit

Global Price Benchmark for Ifosfamide across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	N/A	USD	Pricing information for Ifosfamide 500mg is not publicly disclosed by the FDA or other U.S. government agencies.
United Kingdom	N/A	GBP	The NHS Drug Tariff does not list Ifosfamide 500mg, and specific pricing information is not publicly accessible.
Germany	N/A	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) does not provide public pricing data for Ifosfamide 500mg.
Australia	N/A

Supply Chain Risk Assessment — Ifosfamide

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

Ifosfamide, an alkylating agent used in chemotherapy, relies on Active Pharmaceutical Ingredients (APIs) that are predominantly manufactured in India. However, the production of these APIs is heavily dependent on Key Starting Materials (KSMs) and intermediates, many of which are imported from China. This dependency poses a significant risk, as any disruption in the supply of these materials can halt API production. For instance, in July 2018, environmental regulations led to the shutdown of several Chinese chemical plants, causing a ripple effect that impacted global pharmaceutical supply chains, including those in India.

The concentration of KSM production in China is notable, with the country controlling approximately 70–80% of the global KSM supply. This monopolization means that any geopolitical tensions, trade restrictions, or internal policy changes within China can have immediate and profound effects on the availability and cost of essential raw materials for Ifosfamide production in India.

2Supplier Concentration & Single-Source Risk

The export market for Ifosfamide from India is notably concentrated among a few key players. The top five exporters—VIVALIA REMEDIES PRIVATE LIMITED, UNITED BIOTECH PRIVATE LIMITED, GETWELL PHARMACEUTICALS, KWALITY PHARMACEUTICALS LIMITED, and DAB PHARMA—collectively account for 62.3% of the total export value, with VIVALIA REMEDIES alone contributing 24.9%. This high level of supplier concentration increases the risk of supply chain disruptions, as issues affecting any of these major exporters could significantly impact the overall availability of Ifosfamide in international markets.

Access Complete Ifosfamide Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 732 transactions across 80 markets.

Request Demo View Pricing

Frequently Asked Questions — Ifosfamide Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top ifosfamide exporters from India?

The leading ifosfamide exporters from India are VIVALIA REMEDIES PRIVATE LIMITED, UNITED BIOTECH PRIVATE LIMITED, GETWELL PHARMACEUTICALS, and 11 others. VIVALIA REMEDIES PRIVATE LIMITED leads with 24.9% market share ($608.7K). The top 5 suppliers together control 62.3% of total export value.

What is the total export value of ifosfamide from India?

The total export value of ifosfamide from India is $2.4M, recorded across 732 shipments from 152 active exporters to 80 countries. The average shipment value is $3.3K.

Which countries import ifosfamide from India?

India exports ifosfamide to 80 countries. The top importing countries are UZBEKISTAN (25.1%), PHILIPPINES (12.8%), PERU (11.5%), PAKISTAN (6.2%), VENEZUELA (5.2%), which together account for 60.7% of total export value.

What is the HS code for ifosfamide exports from India?

The primary HS code for ifosfamide exports from India is 30049049. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Ifosfamide

Ifosfamide

Top Ifosfamide Exporters from India

Top Countries Importing Ifosfamide from India

Who Supplies Ifosfamide to India?

Quick Facts

Related Advanced Oncology

Related Analysis

Need Details?

Regulatory Landscape — Ifosfamide

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Ifosfamide

Supply Chain Risk Assessment — Ifosfamide

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Ifosfamide Trade Intelligence

Frequently Asked Questions — Ifosfamide Exports from India

Who are the top ifosfamide exporters from India?

What is the total export value of ifosfamide from India?

Which countries import ifosfamide from India?

What is the HS code for ifosfamide exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of ifosfamide exports from India?

Which ports handle ifosfamide exports from India?

Why is India a leading exporter of ifosfamide?

What certifications do Indian ifosfamide exporters need?

How many buyers import ifosfamide from India?

What is the market share of the top ifosfamide exporter from India?

Analysis Methodology